Theriva Biologics, Inc.
Pharmaceutical Preparations · Rockville, MD, United States
- PrincipalsSteven A ShallcrossCEO and CFOand 3 more
- CompanyTheriva Biologics, Inc.Rockville, MD, United States
- Phone line+1 (734) 332-7800General business
Theriva Biologics, Inc. is an SEC-registered NYSE-listed company (ticker TOVX) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 4
Chief executive
Steven A ShallcrossCEO and CFO
Chair & board
Jeffrey Alan WolfDirector (Board)
Jeffrey J KrawsDirector (Board)
John J MonahanDirector (Board)
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Steven A Shallcross — CEO and CFO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Jeffrey Alan Wolf — Director (Board)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Jeffrey J Kraws — Director (Board)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗John J Monahan — Director (Board)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Roivant Sciences Ltd.Pharmaceutical Preparations · London1 shared capabilityTeva Pharmaceutical Industries LtdPharmaceutical Preparations · Tel Aviv1 shared capabilityDBV Technologies S.A.Biological Products, (No Diagnostic Substances) · Chatillon1 shared capabilityEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityCrispr Therapeutics AGBiological Products, (No Diagnostic Substances) · Zug1 shared capabilityXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityMereo BioPharma Group plcPharmaceutical Preparations · London1 shared capability